Founder And CEO, Dare Bioscience
In 2015, Sabrina Johnson founded Daré Bioscience, a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s reproductive health. Daré in July 2017 completed a reverse merger with Cerulean Pharma Inc. to get access to capital. Over the past 18 months the company has licensed two clinical-stage product candidates and has an extensive pipeline of preclinical candidates. She serves on the boards of Aethlon Medical Inc., a publicly-traded company; the YWCA of San Diego County as past president; PPPSW; Athena San Diego; and the Clearity Foundation.
American Graduate School of International Management, University of London, University College London, Tulane University
She was born in Rome and named the company Daré, which in Italian means “give” and in English means “to be bold.”